The Biotech investment specialists

WM Consulting is an independent financial advisory firm specialising in investments in biotechnology.

We are the ideal partner for those who want a high level of service that allows investors to seize all the opportunities in the biotechnology market.

Successfully invest in the medicine of future

More than 70% of molecules in early stage development are of biotechnological origin.

Biotech drugs will dominate the market in the coming years.

WM Consulting is a partner with over 15 years of experience in the industry.

Successfully invest in the medicine of future

DNA and BIOTECH

DNA mapping has laid the foundations for one of the most important revolutions in the entire history of human civilization.

The turnover of biotech companies has grown at very high speed

Fundamental analysis of biotech companies is the basis of our evaluation and selection method.

WM Consulting S.C.F.

WM Consulting is an independent financial advisory company specialized in Biotechnology investments.

Founded in 2003, we support our Private and Institution Clients in choosing the right investments using our proprietary analysis.

We put our long and successful experience in biotech investments at your diposal.

Our Method

DISCOVER
FOLLOW
STUDY
EXTENSIVE, IN-DEPTH RESEARCH

Our method is to discover, follow, study and research the best technological platforms and molecules, in order to identify a number of diversified investment opportunities in which we believe. Our advice to clients is to invest in those companies as shareholders and not simply as traders.

Our Knowledge

Our unique expertise is based on both in-depth financial and medical knowledge.

We have a large database of CEOs, scientists, companies and institutions involved in this revolution. Partnerships, mergers and acquisitions are also under constant evaluation.

When advising a portfolio of securities, we diversify according to size, technology, types of diseases in order to be independent of benchmarks.

Our Story

WM Consulting was founded in 2003 as an independent consulting company for private clients. After a long successful track record with private clients, we started working with institutional clients.

In 2012 we became the official advisor of the Multistars WM Biotech, an UCITS investment fund listed in Luxembourg.

Since 2014 we advise Zeus Asset Management Luxembourg which manage the Zeus Capital Sicav DNA Biotech

In 2015 we advised the Asset Equity Biotech Fund listed in San Marino.

In 2019 WM Consulting received authorization from the Italian OCF (Organismo di vigilanza e tenuta dell'albo unico dei Consulenti Finanziari) to be a licensed SCF (Società di Consulenza Finanziaria - license nr. 624095).

Our values

Long experience, independence, transparency is what our customers recognize in us.